Artificial Intelligence (AI) in Inflammatory Bowel Disease Market (By Technology: Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision; By End-User: Consumer Healthcare, Pharmaceutical Companies, Research And Development Sector; By IBD Type: Crohn’s Disease, Ulcerative Colitis; By Application: Diagnosis, Prognosis, Treatment, Monitoring ) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) In Inflammatory Bowel Disease Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by Technology, 2023-2032
8.1.1. Machine Learning
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Natural Language Processing
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Context-Aware Computing
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Computer Vision
8.1.4.1. Market Revenue and Forecast (2020-2032)
9.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by End-User, 2023-2032
9.1.1. Consumer Healthcare
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Research And Development Sector
9.1.3.1. Market Revenue and Forecast (2020-2032)
10.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by IBD Type, 2023-2032
10.1.1. Crohn’s Disease
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Ulcerative Colitis
10.1.2.1. Market Revenue and Forecast (2020-2032)
11.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by Application, 2023-2032
11.1.1. Diagnosis
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Prognosis
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Treatment
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Monitoring
11.1.4.1. Market Revenue and Forecast (2020-2032)
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2020-2032)
12.1.2. Market Revenue and Forecast, by End-User (2020-2032)
12.1.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.1.4. Market Revenue and Forecast, by Application (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2020-2032)
12.1.5.2. Market Revenue and Forecast, by End-User (2020-2032)
12.1.5.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.1.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)
12.1.6.2. Market Revenue and Forecast, by End-User (2020-2032)
12.1.6.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.1.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2020-2032)
12.2.2. Market Revenue and Forecast, by End-User (2020-2032)
12.2.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.2.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2020-2032)
12.2.5.2. Market Revenue and Forecast, by End-User (2020-2032)
12.2.5.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.2.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)
12.2.6.2. Market Revenue and Forecast, by End-User (2020-2032)
12.2.6.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.2.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2020-2032)
12.2.7.2. Market Revenue and Forecast, by End-User (2020-2032)
12.2.7.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.2.7.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2020-2032)
12.2.8.2. Market Revenue and Forecast, by End-User (2020-2032)
12.2.8.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.2.8.4. Market Revenue and Forecast, by Application (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2020-2032)
12.3.2. Market Revenue and Forecast, by End-User (2020-2032)
12.3.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.3.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2020-2032)
12.3.5.2. Market Revenue and Forecast, by End-User (2020-2032)
12.3.5.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.3.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)
12.3.6.2. Market Revenue and Forecast, by End-User (2020-2032)
12.3.6.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.3.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2020-2032)
12.3.7.2. Market Revenue and Forecast, by End-User (2020-2032)
12.3.7.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.3.7.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)
12.3.8.2. Market Revenue and Forecast, by End-User (2020-2032)
12.3.8.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.3.8.4. Market Revenue and Forecast, by Application (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2020-2032)
12.4.2. Market Revenue and Forecast, by End-User (2020-2032)
12.4.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.4.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2020-2032)
12.4.5.2. Market Revenue and Forecast, by End-User (2020-2032)
12.4.5.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.4.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)
12.4.6.2. Market Revenue and Forecast, by End-User (2020-2032)
12.4.6.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.4.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2020-2032)
12.4.7.2. Market Revenue and Forecast, by End-User (2020-2032)
12.4.7.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.4.7.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)
12.4.8.2. Market Revenue and Forecast, by End-User (2020-2032)
12.4.8.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.4.8.4. Market Revenue and Forecast, by Application (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2020-2032)
12.5.2. Market Revenue and Forecast, by End-User (2020-2032)
12.5.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2020-2032)
12.5.5.2. Market Revenue and Forecast, by End-User (2020-2032)
12.5.5.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.5.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)
12.5.6.2. Market Revenue and Forecast, by End-User (2020-2032)
12.5.6.3. Market Revenue and Forecast, by IBD Type (2020-2032)
12.5.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.1. IBM
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Google AI
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Microsoft
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. GE Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Johnson & Johnson
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Philips Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Nuance Communications
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Zebra Technologies
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Medtronic
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Boston Scientific
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample